Futuximab
Product Specifications
UNSPSC Description
Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity[1].
Target Antigen
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/futuximab.html
Solubility
10 mM in DMSO
Smiles
[Futuximab]
References & Citations
[1]Stephen T Keir, et al. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. J Neurooncol. 2018 Jul;138(3):489-498.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99628/Futuximab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99628/
Clinical Information
Phase 2
CAS Number
1310460-85-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1237224-01 0.05 mg (E-Coli)
Recombinant Opisthacanthus cayaporum Venom peptide Ocy2
Ask
View Details 
MBS1237224-02 0.2 mg (E-Coli)
Recombinant Opisthacanthus cayaporum Venom peptide Ocy2
Ask
View Details 
MBS1237224-03 0.5 mg (E-Coli)
Recombinant Opisthacanthus cayaporum Venom peptide Ocy2
Ask
View Details MBS1237224-04 0.05 mg (Yeast)
Recombinant Opisthacanthus cayaporum Venom peptide Ocy2
Ask
View Details MBS1237224-05 0.05 mg (Baculovirus)
Recombinant Opisthacanthus cayaporum Venom peptide Ocy2
Ask
View Details